Nevada
|
0-24512
|
88-1273503
|
||
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
ITEM 9.01.
|
FINANCIAL
STATEMENTS AND EXHIBITS.
|
|
(d)
|
EXHIBITS.
|
99.1
|
Press
Release dated August 20, 2010
|
RENHUANG
PHARMACEUTICALS, INC.
|
||||
Date:
August 25, 2010
|
By:
|
/s/
Shaoming Li
|
||
Shaoming
Li
|
||||
Chief
Executive Officer
|